KEY FEATURES
Full Name | Hepatocyte Nuclear Factor 4 Alpha |
---|---|
Synonym | HNF4; HNF4a7; HNF4a8; HNF4a9; MODY; MODY1; NR2A1; NR2A21; TCF; TCF14; Nuclear Receptor Subfamily 2,Group A,Member 1; Transcription factor 14 |
Assay Type | Sandwich |
Reactivity | Human |
Range | 0.15-10ng/mL |
Sensitivity | 0.06ng/mL |
Sample Type | Serum,plasma and other biological fluids |
Sample Volume | 100μL |
Detection Wavelength | OD450 |
Transportation Temperature | 2-8°C |
Specificity | The kit detected Human HNF4a in the samples and no significant cross-species reactions were found |
Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human HNF4a. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human HNF4a and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human HNF4a, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human HNF4a. You can calculate the concentration of Human HNF4a in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
Components | Specifications | Storage and Notes |
---|---|---|
Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human HNF4a ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
Intra-assay Precision | Inter-assay Precision | |||||
---|---|---|---|---|---|---|
Sample | 1 | 2 | 3 | 1 | 2 | 3 |
n | 20 | 20 | 20 | 20 | 20 | 20 |
Mean (ng/mL) | 0.5 | 1 | 3.67 | 0.47 | 0.94 | 3.57 |
Standard deviation | 0.03 | 0.06 | 0.16 | 0.03 | 0.04 | 0.19 |
CV(%) | 5.46 | 5.71 | 4.28 | 5.52 | 4.17 | 5.46 |
RECOVERY
The recovery of Human HNF4a spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
Sample Type | Range (%) | Average Recovery (%) |
---|---|---|
Serum(n=8) | 85-96 | 90 |
EDTA plasma (n=8) | 88-102 | 94 |
Cell culture media (n=8) | 83-95 | 90 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human HNF4a in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with HNF4a ELISA Kits
Hnf1a antibody pair kit | publications with HNF4a and Hnf1a |
Gck antibody pair kit | publications with HNF4a and Gck |
Foxa2 antibody pair kit | publications with HNF4a and Foxa2 |
Srebf1 antibody pair kit | publications with HNF4a and Srebf1 |
Onecut1 antibody pair kit | publications with HNF4a and Onecut1 |
Ttr antibody pair kit | publications with HNF4a and Ttr |
Apoc3 antibody pair kit | publications with HNF4a and Apoc3 |
Apoa1 antibody pair kit | publications with HNF4a and Apoa1 |
G6pc antibody pair kit | publications with HNF4a and G6pc |
Med1 antibody pair kit | publications with HNF4a and Med1 |
Pathways associated with HNF4a ELISA Kit
AMPK Signaling Pathway | AMPK Signaling Pathway |
Developmental Biology Pathway | Developmental Biology Pathway |
Gene Expression Pathway | Gene Expression Pathway |
Generic Transcription Pathway | Generic Transcription Pathway |
Maturity Onset Diabetes Of The Young Pathway | Maturity Onset Diabetes Of The Young Pathway |
Nuclear Receptor Transcription Pathway | Nuclear Receptor Transcription Pathway |
Nuclear Receptors Pathway | Nuclear Receptors Pathway |
Regulation Of Beta-cell Development Pathway | Regulation Of Beta-cell Development Pathway |
Diseases associated with HNF4a ELISA Kit
Diabetes Mellitus | publications with HNF4a and Diabetes Mellitus |
Diabetes Mellitus, Type 2 | publications with HNF4a and Diabetes Mellitus, Type 2 |
Liver Diseases | publications with HNF4a and Liver Diseases |
Carcinoma, Hepatocellular | publications with HNF4a and Carcinoma, Hepatocellular |
Liver Neoplasms | publications with HNF4a and Liver Neoplasms |
Fatty Liver | publications with HNF4a and Fatty Liver |
Hyperglycemia | publications with HNF4a and Hyperglycemia |
Inflammation | publications with HNF4a and Inflammation |
Insulin Resistance | publications with HNF4a and Insulin Resistance |
Hepatitis | publications with HNF4a and Hepatitis |
Organs/Tissues associated with HNF4a ELISA Kit
Liver | publications with HNF4a and Liver |
Pancreas | publications with HNF4a and Pancreas |
Kidney | publications with HNF4a and Kidney |
Intestine | publications with HNF4a and Intestine |
Embryonic Tissue | publications with HNF4a and Embryonic Tissue |
Stomach | publications with HNF4a and Stomach |
Bone Marrow | publications with HNF4a and Bone Marrow |
Spleen | publications with HNF4a and Spleen |
Uncharacterized Tissue | publications with HNF4a and Uncharacterized Tissue |